Toxys is a part of Fraunhofer ITEM led consortium in an EMA-funded research project
January 31, 2022
Toxys is excited to be a part of the consortium led by Fraunhofer ITEM that will shed light on the mutagenicity of different classes of N-Nitrosamines. This joint research project funded by the European Medicines Agency (EMA) will develop in vitro test systems, aiming to improve risk assessment for this class of compounds.
Please click here to read the press release by Fraunhofer here: https://www.item.fraunhofer.de/en/press-and-media/press-releases/mutagenicity-of-nitrosamines.html